2013
DOI: 10.4238/2013.november.18.10
|View full text |Cite
|
Sign up to set email alerts
|

Decreased expression of PIAS1 and PIAS3 in essential thrombocythemia patients

Abstract: ABSTRACT. Gain of function mutation of Janus kinase 2 (JAK2V617F) has been identified in Philadelphia-negative myeloproliferative diseases; about half of essential thrombocythemia (ET) patients harbor this mutation. The activated JAK-STAT pathway promotes cell proliferation, differentiation and anti-apoptosis. We studied the role of negative regulators of the JAK-STAT pathway, PIAS, and SOCS in ET patients. Twenty ET patients and 20 healthy individuals were enrolled in the study. Thirteen of the ET patients ha… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2014
2014
2019
2019

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 25 publications
0
2
0
Order By: Relevance
“…The high frequency point mutations in JAK2 exon 12 (G mutates into T at site 1849) are believed to lead to a valine changing into a phenylalanine at site 617 of the JAK2 kinase domain structure. This change causes instability in, and abnormal activation of, the JH2 structure and further activation of transcription in the cell proliferation gene via activation of the JAK/STAT signal transduction pathways, resulting in sustained cellular proliferation (Harrison et al, 2012;Evrot et al, 2013;Hsiao et al, 2013). In this study, we showed that the mutation was found in 44 of 68 patients with MPN (64.7%), including 24 ET, 17 PV, and 3 PMF patients.…”
Section: Discussionmentioning
confidence: 64%
“…The high frequency point mutations in JAK2 exon 12 (G mutates into T at site 1849) are believed to lead to a valine changing into a phenylalanine at site 617 of the JAK2 kinase domain structure. This change causes instability in, and abnormal activation of, the JH2 structure and further activation of transcription in the cell proliferation gene via activation of the JAK/STAT signal transduction pathways, resulting in sustained cellular proliferation (Harrison et al, 2012;Evrot et al, 2013;Hsiao et al, 2013). In this study, we showed that the mutation was found in 44 of 68 patients with MPN (64.7%), including 24 ET, 17 PV, and 3 PMF patients.…”
Section: Discussionmentioning
confidence: 64%
“…Based on the function of PIAS3 on inhibiting cell proliferation [16] [17] and the response of STAT3 to radiation [18] [19], we will further investigate the inhibiting effect of Ad-pig3RRP-PIAS3 on metastasis which is induced by radiation in lung adenocarcinoma cells and the correlation mechanism. From a new perspective, a novel target and treatment means which combined molecular target therapy with radiotherapy will be explored in lung adenocarcinoma.…”
Section: Discussionmentioning
confidence: 99%